Latest news with #Telmisartan
&w=3840&q=100)
Business Standard
30-07-2025
- Health
- Business Standard
Govt scheme helps Indians save money on medicines: You can benefit, too
Medicine costs can weigh heavily on household budgets, especially for those managing chronic conditions. But the government says that its scheme is helping Indians manage such costs. Jan Aushadhi Kendras (JAKs) have helped citizens to save around Rs 38,000 crore in 11 years, according to data presented to Parliament by the Ministry of Chemicals and Fertilisers. There were 16,912 Jan Aushadhi stores nationwide as of June, providing affordable generic medicines and surgical products, according to a PTI report. What is the Jan Aushadhi scheme? Launched in 2008 and revamped in 2015, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) aims to make quality medicines available at affordable prices. Generic drugs, sold under their chemical name rather than a brand, are said to be just as effective as their branded counterparts. According to PMBJP's website, the scheme covers: -2,110 medicines and 315 surgical products -61 surgical equipment categories -Medicines priced 50-80 per cent lower than popular branded options Health care costs PTI reported, Anupriya Patel, Minister of State for Health and Family Welfare, told Rajya Sabha the scheme has helped people to reduce their out-of-pocket expenses on health. According to data from National Health Accounts, such expenses fell from 62.6 per cent of total health expenditure in 2014-15 to 39.4 per cent in 2021-22. The government now plans to expand the network to 25,000 kendras by March 2027. Branded vs Jan Aushadhi: A quick comparison A look at the price list of common medicines shows the steep difference between Jan Aushadhi and branded products: Medicine Name Jan Aushadhi Price (₹) Popular Brand Price (₹) Telmisartan 40mg (BP) 2.26 (per tab) 10–12 Metformin 500mg 1.06 (per tab) 4–6 Atorvastatin 10mg 3.19 (per tab) 7–10 Pantoprazole 40mg 2.20 (per tab) 6–8 Amoxicillin 500mg 1.80 (per cap) 5–7 Paracetamol 500mg 0.7 (per tab) 1-3 Source: Jan Aushadhi price list, 30 July 2025; market rates from pharmacy portals Should you switch? If you're managing long-term health conditions like diabetes, hypertension, or acidity, switching to Jan Aushadhi equivalents could lead to monthly savings. However, always consult your doctor before switching brands, as not all formulations may be identical in inactive ingredients or in dosage form.
New Indian Express
06-06-2025
- New Indian Express
Illegally stocked drugs worth Rs 5.21 lakh seized
HYDERABAD: The Drugs Control Administration (DCA) raided the residence of a habitual offender in Moosarambagh, Malakpet, and seized spurious drugs worth Rs 5.21 lakh. The accused, Puvvada Lakshmana, is a repeat offender previously involved in multiple spurious drug cases across the state. He had illegally stocked a large quantity of drugs at his home. During the raid, four varieties of suspected spurious medicines were seized, including antidiabetics, antihypertensives, and abortion kits. Acting on a tip-off, DCA officials raided the premises on Wednesday and recovered drugs such as Tazloc-CT 6.25 (Telmisartan and Chlorthalidone tablets), Dapacose-10 (Dapagliflozin tablets 10 mg), Dapacose-5 (Dapagliflozin tablets 5 mg), and Clear-Kit (combipack of Mifepristone and Misoprostol tablets). Samples have been sent for analysis. Officials confirmed that further investigation is underway, and legal action will be taken against all those involved.
Hans India
06-06-2025
- Hans India
DCA seizes counterfeit drugs worth Rs 5.21 lakh
Hyderabad: The Telangana Drugs Control Administration (DCA) seized spurious drugs worth Rs 5.21 lakh during a raid at a residence in Moosarambagh, Malakpet. The drugs included antidiabetics, antihypertensives, and abortion kits. Acting on information about the illegal storage of drugs at an unlicensed premise, the DCA raided the residence in Moosarambagh, Malakpet, and arrested Puvvada Lakshmana. He was involved in multiple cases related to the stocking and sale of counterfeit drugs. According to the DCA, he had illegally stored a large quantity of pharmaceutical products at his residence. During the raid, DCA officials confiscated stocks of Tazloc-CT 6.25 (Telmisartan and Chlorthalidone Tablets), Batch No. M241009, with a manufacturing date of August 2024 and an expiry date of July 2026. The drugs were falsely claimed to be manufactured by Madras Pharmaceuticals, Karapakkam, Chennai, and marketed by USV Pvt. Ltd., Mumbai. They also seized Dapacose-10 Tablets (Dapagliflozin Tablets 10 mg), Batch No. YTQD24010 (Mfg: August 2024, Exp: July 2026), and Dapacose-5 Tablets (5 mg), Batch No. YTQS24004 (Mfg: June 2024, Exp: May 2026), allegedly manufactured by InnovaCaptab Ltd., Solan, Himachal Pradesh, and marketed by J.B. Chemicals & Pharmaceuticals Ltd., Mumbai. In addition, Clear-Kit Tablets (a combi-pack of Mifepristone and Misoprostol), Batch No. MHT25038 (Mfg: March 2025, Exp: February 2027), were seized. These were falsely claimed to be manufactured by Maxcare Laboratories Pvt. Ltd., Dehradun, Uttarakhand, and marketed by Medley Pharmaceuticals Ltd., Mumbai. Samples of the seized drugs have been collected for analysis. Officials said that further investigation is underway. The DCA urged the public to report any suspected illegal drug manufacturing activities via their toll-free number 1800-599-6969 or by calling during working hours (10:30 am to 5:00 pm) on all working days.
Time of India
14-05-2025
- Health
- Time of India
Drug control scanner on 51 below-quality meds, list sent to retailers & wholesalers
Kolkata: The West Bengal Drug Control has found 51 medicines, manufactured by various pharma companies, which failed quality tests. A list for the same has been sent to the wholesalers and retailers of medicines in the state. In the notification dated May 2, the deputy director of Drugs Control has pointed out at least 45 medicines which are not of standard quality. At least five medicines are termed as spurious and one medicine was found to be 'misbranded'.Many of these medicines were drawn and tested by the Food and Drug Administration at Mumbai. Of the list of medicines, the directorate found batches of a number of medicines which are of daily use.A batch of Acelofenac, a nonsteroidal anti-inflammatory drug used for the relief of pain and inflammation in rheumatoid arthritis, was manufactured by an India govt enterprise. Another batch of Cefuroxime Axetil, used in the treatment of bacterial infection was also manufactured by the same enterprise. Both the medicines were found to be not of standard quality.A batch of Telmisartan, used in the treatment of high blood pressure and hypertension was also found to be not of standard quality. It was manufactured by one of the largest pharma companies in India.
